T-Let 40 Tablet
Marketer
Caplet India Pvt Ltd
Salt Composition
Telmisartan (40mg)
Overview T-Let 40 Tablet
CardioGuard 40mg tablets manage hypertension and congestive heart failure. Reducing blood pressure minimizes the risk of future strokes and myocardial infarctions. This medication also safeguards kidney function in diabetic patients. CardioGuard 40mg may be administered independently or alongside other therapies, with or without food, at any time of day. Consistent daily dosing maximizes efficacy. Continued use is vital, even with controlled blood pressure or feeling well; discontinuation can worsen the condition, despite asymptomatic hypertension in many individuals. This widely prescribed medication boasts a strong safety profile for prolonged use. Lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and dietary sodium reduction (as advised by your physician), further enhance blood pressure control. Generally well-tolerated, potential side effects, including hypotension, are uncommon. Report any adverse effects to your doctor; dosage adjustments or alternative treatments may be necessary. Prior to commencing treatment, inform your physician of any pre-existing liver or kidney conditions. Pregnant or lactating women should seek medical consultation before initiating therapy. Regular monitoring of kidney function, blood pressure, and serum potassium levels may be conducted during treatment.
Uses of T-Let 40 Tablet
Managing high blood pressure | Cardiac insufficiency treatment | Pyrexia | Cardiovascular event prophylaxis
Major Benefits of T-Let 40 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. T-Let 40 Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of T-Let 40 Tablet:
- Diarrhea
- Upper respiratory tract infection
- Back pain
- Sinus inflammation
- Skin ulcer
- Intermittent claudication
How to use T-Let 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not break, crush, or chew it. T-Let 40 Tablets can be administered with or without food, although consistent timing is recommended.
How T-Let 40 Tablet works:
Let 40 tablets contain an angiotensin receptor blocker (ARB) that works by inhibiting a vasoconstricting substance. This leads to vasodilation, reducing blood pressure and improving blood flow throughout the body, thereby enhancing cardiac function.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking T-Let 40 Tablet.
PregnancyCONSULT YOUR DOCTOR
Using T-Let 40 Tablets during pregnancy poses a known risk to the fetus. Its use should be avoided except in life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on T-Let 40 Tablet use while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Using T-Let 40 Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use T-Let 40 Tablet cautiously, potentially requiring dosage modification. Consult your physician; disclose any pre-existing kidney conditions. Your doctor may recommend routine monitoring of blood pressure, creatinine, and potassium levels during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using T-Let 40 Tablets, potentially requiring dosage modification under medical supervision. T-Let 40 Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take T-Let 40 Tablet :
Omit any missed T-Let 40 Tablet dose; resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About T-Let 40 Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | HEART |


